<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03555643</url>
  </required_header>
  <id_info>
    <org_study_id>2016-591N-MA</org_study_id>
    <nct_id>NCT03555643</nct_id>
  </id_info>
  <brief_title>Evaluation of the HARM for the Detection of a Cerebral Ischemia in TIA/TNA Patients</brief_title>
  <official_title>Evaluation of the Hyperintense Acute Reperfusion Marker for the Detection of a Cerebral Ischemia in the Anterior and Posterior Circulation in Patients With Transient Ischemic/Neurological Attack</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsmedizin Mannheim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsmedizin Mannheim</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The research project investigates the incidence of the hyperintense acute reperfusion marker
      (HARM) in patients with transient ischemic attack (TIA) or transient neurological attack
      (TNA). Initially, HARM was described after acute ischemic stroke and is caused by a
      blood-brain barrier disorder after recanalization of an acute vessel occlusion and
      consecutive reperfusion. These result in a contrast agent extravasation into the subarachnoid
      space, which can be easily detected on fluid attenuated inversion recovery (FLAIR) images.

      TIA is defined as a transient focal neurological deficit with a probably cerebrovascular
      cause. In contrast, TNA is defined as a transient non-focal neurological deficit with
      multiple causes, including cerebrovascular. The clinical diagnosis of TIA is often flawed and
      the delineation of TIA and TNA can be difficult. MRI is the most important diagnostic method
      for the detection or exclusion of cerebral ischemia in patients with TIA/TNA in daily
      clinical practice. However, on diffusion-weighted imaging (DWI) approximately two-thirds of
      TIA cases and only one-fifth of TNA cases demonstrate acute cerebral ischemia. Supplementary
      perfusion-weighted imaging (PWI) scans can only slightly increase this percentage. The
      well-known HARM could prove to be complementary to DWI and PWI and close or at least reduce
      the existing gap. In the case of TNA in particular, this could be of clinical relevance in
      order to avoid mistreatment or even dismissal without further clarification after supposedly
      inconspicuous imaging.

      Therefore, the aim of this study is to record the incidence of HARM in a statistically
      significant number of cases of patients with TIA and TNA and to investigate relationships
      with symptom duration and anatomical localization. In addition, the dynamics of contrast
      enhancement in the subarachnoid space in TIA and TNA cases with HARM will be analyzed in
      detail.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Anticipated">October 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>hyperintense acute reperfusion marker (HARM)</measure>
    <time_frame>within 24 hours after onset of symptoms</time_frame>
    <description>Detection of the hyperintense acute reperfusion marker (HARM) on postcontrast FLAIR images.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>TIA</condition>
  <condition>Stroke</condition>
  <condition>Ischemia</condition>
  <condition>Diagnoses Disease</condition>
  <arm_group>
    <arm_group_label>transient ischemic attack (TIA)</arm_group_label>
    <description>Patients with transient ischemic attack</description>
  </arm_group>
  <arm_group>
    <arm_group_label>transient neurological attack (TNA)</arm_group_label>
    <description>Patients with transient neurological attack</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients (≥ 50 years) with transient focal or non-focal neurological symptoms who are
        eligible for an MRI examination within 24 hours after onset of symptoms and able to give
        informed consent.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  transient focal neurological symptoms (aphasia, facial paresis, hemiparesis,
             hemihypaesthesia, double vision, hemianopia, hemiataxia, etc.)

          -  transient non-focal neurological symptoms (confusion, dizziness, memory deficits, gait
             insecurity, bilateral weakness, etc.)

          -  MRI examination possible within 24 hours of symptoms

          -  able to give informed consent

        Exclusion Criteria:

          -  persistent symptoms

          -  symptoms lasting more than &gt; 24 h

          -  clinical suspicion of other cause of symptoms (seizures, intoxication, hypoglycemia,
             psychogenic)

          -  contraindications for MRI (pacemaker, metallic splinter, cochlear implants, etc.)

          -  unable to give consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alex Förster, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsmedizin Mannheim, Dept. of Neuroradiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alex Förster, MD</last_name>
    <phone>00496213832443</phone>
    <email>alex.foerster@umm.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universitätsmedizin Mannheim</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alex Förster, MD</last_name>
      <phone>00496213832443</phone>
      <email>alex.foerster@umm.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>June 1, 2018</study_first_submitted>
  <study_first_submitted_qc>June 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 13, 2018</study_first_posted>
  <last_update_submitted>September 24, 2019</last_update_submitted>
  <last_update_submitted_qc>September 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsmedizin Mannheim</investigator_affiliation>
    <investigator_full_name>Alex Förster</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>TIA</keyword>
  <keyword>Stroke</keyword>
  <keyword>Ischemia</keyword>
  <keyword>MRI</keyword>
  <keyword>FLAIR</keyword>
  <keyword>hyperintense acute reperfusion marker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

